
Doctor Ola Vedin
AstraZeneca, Molndal (Sweden)
Follow
Contributor content
Presentation
Early real-world implementation of sacubitril/valsartan in Sweden
Presentation
Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure
Presentation

